Pfizer/BioNTech Expect Data on Shot’s Protection Against New COVID-19 Variant Soon

FRANKFURT — BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine whether its vaccine produced with partner Pfizer Inc would have to be reworked. Read More